Angela Genge
Director, Clinical Research Unit, MNI
Her involvement in clinical research began while still a resident in Neurology. She began assisting Dr. Gordon Francis, the founding director of the CRU at the Montreal Neurological Institute in early trials in both Multiple Sclerosis, and NeuroAIDS. She became involved in ALS research in 1995 and has since expanded to become one of the leaders in international ALS clinical trials.
Her clinical interests in neurology continue to be focused on ALS and neuromuscular diseases. She is continuing to work on expanding the CRU to include clinical trials in orphan neuromuscular disorders, ALS, as well as increasing the MNI clinical research presence in all
Newfoundland born, Dr. Angela Genge completed her medical degree at Memorial University of Newfoundland. She completed her Canadian and American certifications in Internal Medicine and Neurology prior to completing a fellowship in neuromuscular diseases. She joined the staff
of the Montreal Neurological Institute and Hospital in 1994 and became Director of the ALS Clinic in 1998.
Dr. Genge was appointed Director of the CRU in December 2004 and has expanded both the number and scope of clinical trials in neurological disease. Since her arrival, the CRU has grown in both depth and breath and includes trials in neurosurgical conditions and brain tumors. With this, the CRU staffing has increased and an infusion center has been added for special projects. The future holds promise in successful treatments for ALS, brain tumors, muscle diseases, and primary progressive MS.
